Skip to main content
Home
Center for Technology Transfer & Commercialization
  • Home
  • About
  • Inventors
  • Industry
  • Startup Support
  • News & Events
  • Contact Us
  • Quick Links

Search form

    Chikungunya
    • Facebook icon
    • Twitter icon
    • LinkedIn icon
    • YouTube icon

    Displaying 1 - 3 of 3


    Chikungunya antibody identified at VUMC moves forward

    Chikungunya antibody identified at VUMC moves forward


    • Read more about Chikungunya antibody identified at VUMC moves forward
    Related Categories: 
    antibodies Chikungunya virus James Crowe Jr. Research Vanderbilt Vaccine Center

    VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

    VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody


    • Read more about VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody
    Related Categories: 
    Press release Evotec Evotec SE Chikungunya Vanderbilt Vaccine Center James E. Crowe Jim Crowe EVT894 chikungunya virus monoclonal antibody antibody therapies

    VUMC joins national effort to block global pandemics of potentially lethal viruses

    The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.


    • Read more about VUMC joins national effort to block global pandemics of potentially lethal viruses
    Related Categories: 
    DARPA U.S. Defense Advanced Research Projects Agency Vanderbilt University Medical Center VUMC Vanderbilt Vaccine Center ZIKA Chikungunya
    Center for Technology Transfer & Commercialization
    2100 West End Ave, Suite 750
    Nashville, TN 37203
    Tel: 615.343.2430
     
    © 2014 -2025 Vanderbilt University
    Send message